A flow-injection immunoassay (FI-IA) method with amperometric detection for aflatoxin M1 (AFM1) determination in milk has been developed. The first step consists in an incubation of the sample containing AFM1 (Ag) with fixed amounts of anti-AFM1 antibody (Ab) and of the tracer (Ag * , AFM1 covalently coupled to HRP) until equilibrium is reached. In this mixture a competition occurs between Ag and Ag * for the Ab. The mixture is then injected into a flow system where the separation of the free tracer (Ag * ) and the antibody-bound tracer (AbAg * ) is performed in a column with immobilized Protein G. The antigen-antibody complexes are retained in the column due to the high affinity of the Protein G for the antibody. The activity of the eluted enzyme label is then amperometrically detected.
Introduction
Aflatoxins are highly toxic mycotoxins produced by Aspergillus species growing in a wide range of food and animal feedstuffs [1] . When aflatoxin B1 (AFB1), the most toxic aflatoxin, is ingested by cows, it is transformed into its hydroxylated product, aflatoxin M1 (AFM1), which is then secreted in the milk [2] . Although its toxicity is lower than that of its parent compound, AFM1 is known for its hepatotoxic and carcinogenic effect [3] . Unfortunately, AFM1 is relatively stable during milk pasteurisation and storage as well as during the preparation of various dairy products [4] .
To date, aflatoxins are regulated in many countries world-wide [5] . The current maximum level set by the European Union is 0.05 g/kg for Aflatoxin M1 in milk [6] . To minimize the occurrence of AFM1, it is essential to trace the sources of contamination using rapid, selective, sensitive and cost effective assays.
Several procedures for aflatoxin M1 determination have been developed. Methods based on thin-layer chromatography (TLC), high-performance liquid chromatography (HPLC) or enzyme-linked immunosorbent assay (ELISA) are commonly used in routine analysis [7] . TLC was the first method used for aflatoxin M1 determination, but in the last decade has been almost completely replaced by HPLC and fluorimetric techniques [8] [9] [10] [11] . These techniques require extensive preparation steps and well-trained personnel [12] . Moreover, the reagents and instrumentation used are expensive.
In the last decade the production of specific antibodies for aflatoxins has allowed the development of ELISA methods based on direct or indirect competition [12] [13] [14] . Currently, some colorimetric ELISA kits for AFM1 determination in milk and dairy products are commercially available [15] . The ELISA methods, however, present some drawbacks such as long incubation time, washing and mixing steps.
Responding to the need for more suitable methods, some rapid methods based on the use of biosensors or immunosensors have been proposed in the last years. An immunoaffinity fluorimetric biosensor was assembled in an automated system that can measure up to 50 ppb Aflatoxin M1 [16] , but its detection limit (0.1 ppb) is too high for it to be useful for aflatoxin M1 determination in milk.
Sibanda et al. [17] have developed a membrane-based flow-through enzyme immunoassay. A detection limit of 50 ppt was achieved using a preconcentration step based on an immunoaffinity column, the total assay time being 30 min.
A bilayer lipid membrane (BLM)-based biosensor and related thin-film technology were investigated for AFM1 monitoring of milk using a flow-injection system [18] . This very fast method (four samples per minute) permits a continuous monitoring of milk with a detection limit around 200 ppt.
The aim of our work was to develop a method for AFM1 determination that can combine the rapidity and reproducibility of the flow-injection technique with the high selectivity and sensitivity characteristics of immunochemical reactions. We adapted a generic flow-injection immunoassay (FI-IA) system initially developed for atrazine as a model compound [19] . This was then adapted and applied with very good results for triazine herbicides [20] and alkyl phenol ethoxylate surfactants determination in waste water [21] .
The generic system is based on an off-line incubation of the antigen (Ag, analyte), the tracer (Ag * , enzyme-labelled antigen) and the antibody (Ab) until equilibrium is reached. Then this mixture is introduced into a flow-injection system where the antigen-antibody complexes (AgAb and Ag * Ab) are trapped on the Protein G column, while the free, i.e. unbound, tracer is eluted and detected by measuring the activity of the enzyme label. The reason for using the Protein G column is due to its high affinity for the constant region (Fc region) of immunoglobulins.
Most immunoassays based on the Protein G column separation monitor the fraction of the tracer bound inside the Protein G column as Ag * Ab complex. This choice involves a more complicated scheme since there are four steps: incubation of the reagents, antigen-antibody complex trapping inside the Protein G column, monitoring of the enzyme label by substrate injection and regeneration of the Protein G column by desorption of the antigen-antibody complexes. By contrast, when the free fraction of the tracer (Ag * ) is monitored, a higher sample throughput is obtained and the Protein G column does not need to be regenerated between assays. The regeneration of the Protein G column can be performed after 50-100 assays and is dependent upon the amount of the Ab used.
For AFM1 determination we developed a FI-IA system based on the amperometric detection of horseradish peroxidase (HRP), which serves as the enzymatic label for tracer Ag in the eluate.
Experimental

Reagents, method and instrumentation for FI-IA
Reagents
Rat monoclonal anti-aflatoxin antibody (MAB586P) was purchased from Maine Biotechnology Services (Portland, ME, USA). Stock solutions (100 ppm) of aflatoxin M1 (AFM1), aflatoxin B1 (AFB1), aflatoxin B2 (AFB2), aflatoxin G1 (AFG1) and ochratoxin, obtained from Alexis Biochemicals (Carlsbad, CA, USA) were prepared in methanol (Carlo Erba, Milan, Italy). Protein G immobilized on highly cross-linked (4%) beaded agarose fast flow medium with a binding capacity of 37 mg IgG ml −1 gel was purchased from Sigma (St. Louis, MO, USA).
An AFM1-HRP conjugate from the Ridascreen ® Aflatoxin M1 ELISA kit (R-Biopharm, Darmstadt, Germany) was used. Horseradish peroxidase Type VI-A with an activity of 1310 U mg −1 , 3,3 ,5,5 -tetramethylbenzidine (TMB), hydrogen peroxide 30% (w/v), citric acid (anhydrous), Tween 20 and sodium chloride were from Sigma. Na 2 HPO 4 and NaH 2 PO 4 ·H 2 O were from Carlo Erba. The T-connector valves and PTFE connection tubes (i.d. 0.5 mm) were purchased from Supelco (Bellefonte, PA, USA).
Water produced in a Milli-Q system (Millipore, Beford, MA, USA) was used for preparing all the solutions.
Methods and instrumentation
All affinity reactions were performed off-line by mixing the sample with the tracer (AFM1-HRP) and antibody until equilibrium was reached. The mixture was then introduced via a 20 l injection loop into the flow system using a six-way Rheodyne injection valve, model 7125 (Cotati, CA). A borosilicate glass chromatography column (25 mm length and 0.35 ml bed volume) equipped with frits (PTFE, pore size 100 m) from Omnifit (Rockville Centre, NY, USA) was filled with Protein G agarose beads and inserted in the carrier flow channel after the injection valve ( Fig. 1) . A four channel peristaltic pump, Minipuls 3 (Gilson, France) was used for pumping the following solutions: the carrier of 50 mmol l −1 phosphate buffer, also containing 100 mmol l −1 NaCl, 10 mmol l −1 MgCl 2 and 0.03% (v/v) Tween 20 (channel 1); substrate solutions of 0.5 mmol l −1 TMB prepared in water (channel 2) and 10 mmol l −1 H 2 O 2 prepared in 100 mmol l −1 phosphate-citrate buffer, also containing 100 mmol l −1 NaCl and 0.03 concentration.
Milk sample analysis
Raw and UHT (Ultra high temperature) sterilized milk samples, either spiked or naturally contaminated with AFM1, were provided by Parmalat (Parma, Italy). The fat content in these samples was around 3.5%.
When raw milk samples were analysed, they were first treated by heating for 2 min at 90 • C to inactivate endogenous lactoperoxidase (for UHT milk samples this step was not necessary). Samples were then diluted 1:1 with 100 mM phosphate buffer, pH 6.5, which also contained 200 mM NaCl and 20 mM MgCl 2 , and incubated 60 min off-line with (Ag * w ) and (Ab w ) before injection into the FI-IA system.
Reagents, methods and instrumentation for HPLC method 2.2.1. Reagents and instrumentation
Aflatoxin M1 from Aspergillus flavus were purchased from Sigma and Afla M1 Aflatoxin testing kits (25 columns) were from Vicam (Safe Food, BO, Italy).
The reversed phase HPLC analytical system employed a Nova-Pak C 18 column (60 Å, 4 m, 3.9 × 300 mm) from Waters (Milford, MA, USA) and a Rheodyne injection valve with a 50 l injection loop. The mobile phase was a mixture water-CH 3 CN-CH 3 OH (65:25:10) and the flow rate was 0.8 ml min −1 . Fluorimetric detection was used with 365 nm excitation and 435 nm emission.
Methods for sample preparation
The milk was warmed to 35-37 • C and centrifuged at 3000 g to remove the fat. Fifty mililitre of de-fatted milk was then pipetted into the syringe barrel and allowed to pass through the immunoaffinity column at a rate of 2-3 ml min −1 . The column was washed with 20 ml water at constant flow rate. Finally, Aflatoxin M1 was slowly eluted from the column with 4 ml of acetonitrile and the eluate was collected in a conical tube and evaporated to dryness using a gentle stream of N 2 . The dried product was diluted with 200 l of mobile phase and was injected into the HPLC system.
Results and discussion
Electrochemical detection of enzyme label
The flow-injection immunoassay method proposed here is based on an AFM1 conjugate with horseradish peroxidase (AFM1-HRP) as tracer. HRP catalyses the oxidation reaction of various hydrogen-donating substrates with hydrogen peroxide to produce oxidized substrate and water. One of the most commonly used substrates for the spectrophotometric determination HRP activity is TMB. The successful use of TMB as electrochemical substrate for an HRP-based enzyme immunoassay had already been demonstrated in our lab [22] . In that study, the electrochemical behaviour of both TMB and TMB ox were investigated in order to optimise the conditions for amperometrically determining HRP activity using a flow-injection analysis at a glassy carbon electrode.
A cyclic voltammetric investigation of TMB was carried out using a glassy carbon electrode. The reported results supported the mechanism previously proposed, in which there is formation of a radical cation, and then two subsequent one electron step processes for the oxidation of TMB by HRP in the presence of H 2 O 2 . The most interesting result, in terms of the application considered here, was the generation of an electrocatalytic current (the difference between the cathodic waves in buffer with or without the presence of HRP). Thus, the addition of HRP to a solution containing the two substrates (TMB and H 2 O 2 ) led to the consumption of TMB and consequently to a decrease in the oxidation and an increase in the reduction currents respectively.
Further studies then allowed the choice of a working potential of +100 mV versus Ag/AgCl for the measurement of HRP activity, and these have been adopted for use here. At this potential the current background was near zero and no substrate oxidation occurred. These conditions are the optimum for enzymatic activity determination when a small amount of product (TMB ox ) needs to be measured in the presence of high concentrations of substrate.
Having established the electrochemical system to use, optimisation of the buffer conditions and substrate concentrations for HRP detection was performed for the FIA system shown in Fig. 1, but without the Protein G column inserted. Instead, labelling enzyme (HRP) was injected directly, and a 0.05 U ml −1 HRP solution was chosen for these studies.
The pH of the carrier and substrate solutions were optimised in a first step (results not shown). Since the optimum pH for HRP activity is 8 while that for detection of TMB ox is around 5, a compromise was found so that the pH of the carrier solution was as high as possible while the mixture that resulted in the flow cell would be close to the optimal value for electrochemical detection. Regarding the TMB solution, due to its solubility problems in phosphate-citrate buffer, it was decided to prepare that substrate in distilled water.
Following trials with various buffers and pHs, the best results for HRP activity determination using this flow-injection system were determined to be the following: a carrier solution of 50 mM phosphate buffer, pH 6.5, containing 100 mM NaCl and 10 mM MgCl 2 (which is included as an activator of HRP). For the H 2 O 2 solution, the highest signals were obtained for a 100 mM phosphate-citrate buffer, pH 5.0, with 100 mM NaCl.
The optimum concentrations of TMB and H 2 O 2 to employ for the measurement of HRP activity were then studied using the enzyme concentration reported above. The results, reported in Fig. 2A and B indicated that the highest current outputs were achieved for 0.5 mM TMB and 10 mM H 2 O 2 , respectively. Higher H 2 O 2 concentrations could not be used since above 10 mM the signals became irreproducible and passivation of the electrode was observed. The influence of the length of both mixing and reaction coils was also studied (Fig. 3) . Regarding the mixing coil (for the two enzymatic substrates, see Fig. 1 ), FIA output currents plateaued at 50 cm of length. Using this value, the optimum length for the reaction coil, where the enzymatic reaction takes place, was explored and a much longer tube was found to be necessary. On the basis of these experiments a 50 cm mixing coil and a 200 cm reaction coil were chosen for further work.
Using these optimised conditions for the electrochemical determinination of HRP activity, a calibration curve was obtained and showed good linearity up to 100 mU ml −1 HRP with a LOD of 0.25 mU ml −1 . The good reproducibility (RSD = 2.34%, n = 10) obtained at the detection limit showed that this amperometric method for measuring the HRP tracer was suitable for the determination of AFM1.
Optimisation of flow-injection immunoassay for AFM1 determination
Tracer dilution
The dilution of AFM1-HRP conjugate should be a compromise between the high dilution required to achieve a low detection limit for AFM1 and that needed to produce a sufficiently high signal. The working tracer dilution was defined as the tracer dilution resulting in a signal that was around 100 times the noise (S/N >100) [23, 24] . Different dilutions between 1/400 and 1/50 were tested and a dilution of 1/200 was selected as working tracer concentration [AFM1-HRP] w for the assay.
During the experiments to establish the best tracer concentration, a continuous increase in the baseline current was observed. This effect could be attributed to tracer that was non-specifically absorbed to the tubing. Leakage of the conjugate then gave rise to the continuously increasing background current. In order to avoid this effect, different concentrations of Tween 20, in the range 0.01-1% (v/v), were added to the carrier solution to prevent the absorption. A stable baseline was achieved with a concentration of 0.03% (v/v) Tween 20. Under these improved conditions, a 1/200 dilution of tracer was shown to give a relative standard deviation of 1.65% for n = 12.
Incubation time
In order to establish a suitable incubation time, the Protein G column was re-introduced into the FI-IA system. Solutions of [AFM1-HRP] w were incubated with 1 ppm Ab for different lengths of time and then injected into the flow system to determine the time needed for the off-line antigen-antibody reaction to reach equilibrium. Fig. 4 shows that maximal binding of labelled antigen was observed after 1 h and thus an incubation time of 1 h was used for further experiments.
Flow rate
The flow rate is a parameter that has a significant influence on the retention of antigen-antibody complex by the Protein G column. Fig. 5 shows the ratio obtained between the signal corresponding to the mixture (Ag * + Ab) and the signal obtained just for Ag * introduced using the same flow rate (S Ag * +Ab /S Ag * ) for different overall flow rates. At low flow rates this ratio is relatively high due to the large dispersion of the sample during its transport from the injecting point to the detector. At a flow rate higher then 1.2 ml min −1 the contact time between the antigen-antibody complex and Protein G is not sufficient and the ratio begins to increase. At the flow rate of 0.9 ml min −1 a minimum is obtained, which seems to reflect the optimal separation of Ab-bound tracer from free tracer, with good retention of the immuno complexes by the Protein G. This flow rate was selected for the assay. . Antibody dilution curve: the relative response S Ag * +Ab /S Ag * 100 plotted vs. antibody concentration. S Ag * is the signal for the tracer fraction (Ag * ) without the antibody present in the system and S Ag * +Ab is the signal for the free-eluting tracer when the antibody is present in the system. Working conditions: AFM1-HRP diluted 1/200; 60 min incubation; 10 mM H 2 O 2 ; 0.5 mM TMB; total flow rate 0.9 ml min −1 . Fig. 6 . A logistic equation with four parameters (fitted using a Jandel SigmaPlot 5.00 program) was used to analyse the data. The Ab concentration, which binds 50% of the tracer (Ab 50 ), was found to be 0.57 ppm. In a competitive immunoassay, the working antibody concentration (Ab w ) is normally chosen to correspond to a value giving 30-70% tracer binding, depending on the desired assay properties [24] . In our case a value slightly higher than (Ab 50 ) was chosen (1 ppm), since better signals were obtained in this region of the curve.
Antibody concentration
Characteristics of FI-IA assay
To assess the performance of the system for the determination of AFM1, a calibration was done by incubating various concentrations of AFM1 with a 1/200 dilution of tracer and 1 ppm Ab for 60 min and injecting the samples into the FI-IA system. An increase in the signal (current) was observed with increasing AFM1 concentration. The data were fitted using a logistic equation with four parameters and the IC 50 (analyte concentration at 50% binding of the tracer) was calculated. The FI-IA immunoassay was then evaluated in terms of sensitivity, precision and selectivity (Table 1) on the basis of three different calibration curves obtained on three different days. The assay showed a good precision within the quantification range (20-500 ppt) and a satisfactory detection limit (11 ppt) relative to the requirements for the application of this for AFM1 determination in milk samples for regulatory purposes.
The cross-reactivity of this immunoassay format was studied using other mycotoxins such as AFB1, AFB2, AFG1 and ochratoxin. Calibrations for these cross-reactants were performed and for each cross reactant the corresponding IC 50 was calculated. The relative cross-reactivity (CR) of the tested toxins is presented in Table 2 taking the IC 50 value for AFM1 as reference. Cross-reactivities of 28.9% for AFB1 and 18.5% for AFB2 were obtained. As AFB1 and AFB2 are usually not found in the cow milk, this cross-reaction is not relevant when analysing aflatoxin M1 in this kind of sample [25, 26] .
Real sample analysis
Effect of matrix components on the immunoassay characteristics
The effect of matrix components was evaluated by assay of a raw milk sample, for which a non-detectable AFM1 content was established by use of the HPLC method. Raw milk contained endogenous lactoperoxidase, which was shown to interfere strongly with the monitoring of the free fraction of tracer. Different methods for lactoperoxidase inactivation were tested and the best results were obtained with thermic inactivation, that is by heating the milk for 2 min at 90 • C. After cooling to room temperature, the milk sample was diluted 1:1 with double strength carrier buffer. Fig. 7 shows the AFM1 calibration plots obtained when AFM1 was added either to phosphate buffer or raw milk. Each point in the graph represents the mean of the values obtained for calibrations performed on three different days. As can be seen, the behaviour and the sensitivity were similar in the two situations and good recoveries were obtained.
Analysis of real samples and comparison with HPLC procedure
To assess the accuracy of results obtained with the optimised FI-IA method, an HPLC procedure (AOAC 2000.08) was chosen for comparison. This standard procedure was improved by the introduction of a clean-up step (immunoaffinity column) in the sample treatment procedure. Different UHT and raw milk samples, spiked or naturally contaminated, were analysed with both the procedures and the results, shown in Fig. 8 , were in a satisfactory agreement (R = 0.9726).
Conclusions
The optimised flow-injection immunoassay for AFM1 has been shown to have a good potential as a method for rapid screening of this toxin in raw milk. The detection limit of 20 ppt obtained for milk samples (taking into consideration the dilution 1:1 of the samples) allows the application of this method at dairy industry laboratories.
The sample preparation is very simple and fast (just heating and dilution) in comparison with the HPLC and ELISA procedures.
This assay resulted in a high throughput (six samples in triplicate per hour). The regeneration of the Protein G column (with 0.5 ml 50%) methanol is recommended after 50 injections to keep the column fresh.
This method offers strong advantages, such as good reproducibility (RSD inter-assay < 8%), selectivity (due to the use of a monoclonal antibody), good recoveries (80-120%) and a low consumption of reagents. The results obtained with the FI-IA method are in good agreement with those obtained with the official HPLC procedure. The proposed flow-injection immunoassay system involves low cost instrumentation, is easy to operate and is very suitable to automation.
